These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10594899)

  • 1. Historical overview of topical skin protectant development.
    Romano JA; Filbert MG
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S39. PubMed ID: 10594899
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of reactive topical skin protectants against sulfur mustard and nerve agents.
    Koper O; Lucas E; Klabunde KJ
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S59-70. PubMed ID: 10594903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a reactive topical skin protectant.
    Braue EH
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S47-53. PubMed ID: 10594901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermostyx (IB1) - High efficacy and safe topical skin protectant against percutaneous toxic agents.
    Dachir S; Barness I; Fishbine E; Meshulam J; Sahar R; Eisenkraft A; Amir A; Kadar T
    Chem Biol Interact; 2017 Apr; 267():25-32. PubMed ID: 27417258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the topical skin protectant in advanced development.
    Liu DK; Wannemacher RW; Snider TH; Hayes TL
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S40-5. PubMed ID: 10594900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyoxometalate oxidation of chemical warfare agent simulants in fluorinated media.
    Johnson RP; Hill CL
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S71-5. PubMed ID: 10594904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro tests to assess the efficacy of formulations as topical skin protectants against organophosphorus compounds.
    Millerioux J; Cruz C; Bazire A; Polly V; Lallement G; Lefeuvre L; Josse D
    Toxicol In Vitro; 2009 Feb; 23(1):127-33. PubMed ID: 18951968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of protective ointments used against dermal effects of nitrogen mustard, a vesicant warfare agent.
    Kenar L; Karayilanoğlu T; Yuksel A; Gunhan O; Kose S; Kurt B
    Mil Med; 2005 Jan; 170(1):1-6. PubMed ID: 15724846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A topical skin protectant against chemical warfare agents.
    Kadar T; Fishbine E; Meshulam J; Sahar R; Amir A; Barness I
    Isr Med Assoc J; 2003 Oct; 5(10):717-9. PubMed ID: 14719467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions.
    Wormser U; Sintov A; Brodsky B; Casillas RP; Nyska A
    Arch Toxicol; 2004 Mar; 78(3):156-66. PubMed ID: 14618300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an in vitro screening method for evaluating decontamination of sulfur mustard by reactive dermal formulations.
    Clark CR; Smith JR; Shih ML
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S77-81. PubMed ID: 10594905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of a topical skin protectant against chemical warfare agents.
    Eisenkraft A; Krivoy A; Vidan A; Robenshtok E; Hourvitz A; Dushnitsky T; Markel G
    Mil Med; 2009 Jan; 174(1):47-52. PubMed ID: 19216298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 2: guinea pigs challenged with soman.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):29-37. PubMed ID: 20964500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro human skin permeation and decontamination of diisopropyl methylphosphonate (DIMP) using Dermal Decontamination Gel (DDGel) and Reactive Skin Decontamination Lotion (RSDL) at different timepoints.
    Cao Y; Hui X; Elmahdy A; Maibach H
    Toxicol Lett; 2018 Dec; 299():118-123. PubMed ID: 30282006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 3: Evaluation of in vitro topical decontamination efficacy using damaged skin.
    Lydon HL; Hall CA; Dalton CH; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2017 Aug; 37(8):976-984. PubMed ID: 28218409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection and efficacy of topical skin protectants against the nerve agent VX.
    Millerioux J; Cruz C; Bazire A; Lallement G; Lefeuvre L; Josse D
    Toxicol In Vitro; 2009 Apr; 23(3):539-45. PubMed ID: 19444931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early effects of iodine on DNA synthesis in sulfur mustard-induced skin lesions.
    Brodsky B; Trivedi S; Peddada S; Flagler N; Wormser U; Nyska A
    Arch Toxicol; 2006 Apr; 80(4):212-6. PubMed ID: 16252085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of topical skin protectant on heat exchange in humans.
    Gabarée CL; Mair BS; Kolka MA; Stephenson LA
    Aviat Space Environ Med; 1997 Nov; 68(11):1019-24. PubMed ID: 9383502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of barrier creams against sulphur mustard: (II) In vivo and in vitro studies using the domestic white pig.
    Chilcott RP; Dalton CH; Ashley Z; Allen CE; Bradley ST; Maidment MP; Jenner J; Brown RF; Gwyther RJ; Rice P
    Cutan Ocul Toxicol; 2007; 26(3):235-47. PubMed ID: 17687688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.